SCHEMBL4728823

SCHEMBL4728823

COc1c(-c2cc(Cl)nc(N3CCOCC3)n2)ccc2[nH]c(C(F)F)nc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.41
L3MBTL1 Q9Y468 4/20 0.41
TDP1 Q9NUW8 3/20 0.41
TSHR P16473 3/20 0.41
HSD17B10 Q99714 3/20 0.41
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
MEN1 O00255 1/20 0.41
ALOX15 P16050 1/20 0.41
KMT2A Q03164 1/20 0.41
AGER Q15109 1/20 0.41
PIK3CB P42338 10/20 0.40
PIK3CA P42336 6/20 0.38
PIK3CD O00329 3/20 0.38
PIK3CG P48736 2/20 0.38
AR P10275 1/20 0.37
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4586110 0.83 TDP1 (0.41) KDM4EL3MBTL1TDP1TSHRHSD17B10
SCHEMBL1680073 0.73 PIK3CB (0.40) PIK3CBPIK3CAPIK3CDPIK3CGMTOR
SCHEMBL4585107 0.72 ATR (0.49) PIK3CAPIK3CDPIK3CGCYP2C9MTOR
SCHEMBL4573462 0.69 TDP1 (0.45) KDM4EL3MBTL1TDP1TSHRHSD17B10
SCHEMBL4730042 0.67 PIK3CA (0.44) TSHRHSD17B10MAPTPIK3CBPIK3CA
SCHEMBL4798842 0.67 MTOR (0.50) KDM4EL3MBTL1TDP1HSD17B10LMNA
SCHEMBL4729180 0.66 PIK3CA (0.42) PIK3CBPIK3CAPIK3CDPIK3CGMTOR
SCHEMBL4572918 0.66 PIK3CA (0.41) PIK3CBPIK3CAPIK3CDPIK3CGMTOR
SCHEMBL920268 0.66 ALDH1A1 (0.34)
SCHEMBL3991404 0.66 MAPT (0.51) L3MBTL1MAPTMEN1KMT2APIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008032027-A1 PYRIMIDINE DERIVATIVES ASTRAZENECA AB (SE) 2008-03-20 WO disclosed